TREACE MEDICAL CONCEPTS INC (TMCI)

US89455T1097 - Common Stock

10.4  +0.1 (+0.97%)

After market: 10.4 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
187.12M141.80M94.40M57.40M39.40M
Cost Of Goods
35.18M27.50M17.80M12.50M7.60M
Gross Profit
151.94M114.30M76.60M44.90M31.80M
Operating Expenses
203.37M149.20M93.10M44.00M35.40M
Research and Development
15.44M13.60M10.20M5.80M5.10M
Selling, General, and Administrative Expenses
187.93M135.60M82.90M38.20M30.30M
Operating Income
-51.43M-34.80M-16.50M900.00K-3.50M
Interest Income/Expense
1.56M-3.20M-4.00M-4.50M-700.00K
Other Income/Expense
342.00KN/AN/AN/AN/A
Non Recurring Items
0.00-4.80MN/AN/AN/A
Income Before Taxes
-49.53M-42.80M-20.60M-3.70M-4.30M
Net Income
-49.53M-42.80M-20.70M-4.30M-4.90M
EBITDA
-46.08M-32.67M-15.81M2.11M-2.71M
 
Per Share Data
EPS Diluted Total Ops
-0.81-0.77-0.43-0.09-0.10
Non GAAP EPS
-0.81-0.77-0.41N/AN/A
 
Statistics
Gross Profit Margin
81.20%80.61%81.14%78.22%80.71%
Profit Margin
-26.47%-30.18%-21.93%-7.49%-12.44%
Operating Profit Margin
-27.48%-24.54%-17.48%1.57%-8.88%

All data in USD

Charts